Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

119.50
Delayed Data
As of Mar 22
 +0.44 / +0.37%
Today’s Change
69.12
Today|||52-Week Range
137.88
+6.94%
Year-to-Date
Why Education Could Be The Biggest Beneficiary Of Cannabis Legalization
Mar 16 / Benzinga - Paid Partner Content
No Way! A Profitable Marijuana Stock?
Mar 13 / MotleyFool.com - Paid Partner Content
These 3 Stocks Have Tripled Your Money Over the Past Year
Mar 14 / MotleyFool.com - Paid Partner Content
3 Huge Healthcare Trends and How to Invest in Them (Hint: One Is Marijuana)
Mar 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close119.06
Today’s open118.71
Day’s range118.00 - 120.31
Volume191,576
Average volume (3 months)436,449
Market cap$3.0B
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)-19.04%
Earnings growth (this year)-39.79%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-66.86%
P/E ratio--
Price/Sales205.08
Price/Book5.81

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+2.58+3.99%
PBHPrestige Brands Hold...+0.20+0.36%
ICPTIntercept Pharmaceut...+0.24+0.21%
AKRXAkorn Inc-0.13-0.58%
Data as of 03/22/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$1.34
Annual revenue (last year)$14.6M
Annual profit (last year)-$90.0M
Net profit margin-617.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts


Search for Jobs